This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Crippling Cost Of Pharmaceuticals In The USA At Global Highs And Still Rising

The cost of pharmaceutical drugs in the USA is already high - Americans pay over 50 percent more for drugs than patients elsewhere in the world - and costs are continuing to rise. However, now there are alternatives to purchasing expensive prescription drugs from local American pharmacies.

CINCINNATI, OH, July 9, 2013 /PRNewswire/ - Americans are already paying more for pharmaceutical drugs than patients anywhere else in the world, and these prices are only expected to rise. The average American will spend $1000 on prescription drugs each year; Americans suffering from chronic illnesses and Americans over the age of 65 will pay even more than this each year.

European patients pay far less for prescription medication. Eldepryl, a drug sometimes prescribed to patients with Parkinson's, costs $28 in Italy and $48 in Austria. American patients prescribed this same medication can expect to pay $240. A 2013 study found that Americans pay 54 percent more than Europeans for 25 of the most commonly prescribed medications.

These cripplingly high costs are only expected to increase, and they are increasing at a faster rate than any other medical expenses. This is partly due to the increased cost of medical technologies, the fact that there is no national health plan in the USA and that the USA lets pharmaceutical companies decide for themselves what they will charge.

It is the elderly and the chronically ill who suffer most from these prices, which is why many patients have begun to get their prescriptions from Canadian pharmacy websites such as allows Americans to save up to 80 percent on the prescription medication that they require. Low costs, high quality and doctor-patient confidentiality ensure that all patients' needs are met without burning a hole in their wallet.


1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs